CD14 and coinfection: In the present study, we characterized the role of CD14+CD16+ monocytes in HIV-NCI in the context of viral suppression with a standard ART backbone (tenofovir-emtricitabine), while minimizing effects of confounders by excluding individuals with active substance use and HCV coinfection.